Buy high, sell low: Canopy Growth Corp dumps Auscann pot stock stake

Canopy Growth Corp sells all its Auscann shares for just 15 cents each.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It appears leading Canadian cannabis business Canopy Growth Corp didn't get the 'buy low, sell high' pot stock memo after dumping its 42.08 million shares in Auscann Group Holdings Ltd (ASX: AC8) for just 15 cents per share. 

The block trade equivalent to a 13% stake in Auscann went through last Friday afternoon with Perth-based asset manager Merchant Funds reportedly the buyer.

Remarkably, Auscann shares are changing hands flat at 32 cents per share this morning despite leading medical marijuana player Canopy wanting to get out at 15 cents per share. 

I've warned many times how Auscann looks little more than a 'story stock" endlessly promoted to the media by its former CEO who has since quit with many of the insiders having a background in legislative functions or politics.

The company was set up prior to a series of well flagged legislative announcements making the pathway to commercial medical marijuana in Australia clearer and the stock soared to above $1.70 in January 2018 on the back of little more than promotion and the changing legislative environment. 

For every buyer, there's a seller and for all those who are well underwater on the stock many will have made a fortune.

The only thing Auscann looks to have going for it is a cash balance of around $35 million as at June 30 2019, although this is likely to be whittled away over time as the company has zero revenue and posted a $5 million operating cash loss for fiscal 2019. 

It also tends to promote itself in the media alongside estimates for the growth of 'medical marijuana' markets, rather than its own chances of ever making any money.

Check out page 6 of its latest September 2019 investor presentation which is just media cuttings some of which fall into the "churnalism" bucket of re-purposed public relations releases. 

Source: Auscann presentation, Sept 11, 2019.

I would not go anywhere near this business myself and wouldn't value it at anymore than its cash backing (given cash is likely to be eroded in FY 20) which is a little less than the 15 cents per share Canopy got out at. 

Other pot stocks to have predictably come back to financial reality include Cann Group Holdings Ltd (ASX: CAN), Althea Group Holdings Ltd (ASX: AGH) and MGC Pharmaceuticals Ltd (ASX: MXC).

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Share Market News

2 high-profile ASX 200 transport shares making big news today

Good news is giving these shares a lift this morning. What's happening?

Read more »

Miner looking at a tablet.
Broker Notes

Should you buy the dip on South32 shares?

Could the sell-off be a buying opportunity?

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.

Are Goodman or NAB shares a better buy?

Both of these blue chips have been excellent in 2024. Which is the better buy?

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Why did this top broker just downgrade DroneShield shares?

The broker believes its shares are fully valued at current levels.

Read more »

A female Woolworths customer leans on her shopping trolley as she rests her chin in her hand thinking about what to buy for dinner while also wondering why the Woolworths share price isn't doing as well as Coles recently
Broker Notes

Woolworths shares 'less placed' says top broker

Could the supermarket giant's share price be under pressure?

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Tuesday

The Australian share market is expected to return to form today.

Read more »

Man on a laptop thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield-eque start to the trading week this Monday.

Read more »

A young boy with a sombre face looks down at the zip fastener at the bottom of his jacket as he concentrates on unfastening the clasp.
BNPL shares

What's happening with Zip shares on their first day back aboard the ASX 200?

After a strong eight month run, Zip shares are once again part of the ASX 200.

Read more »